课题基金 / 基金详情

Regulatory role of phosphorylation of tumor suppressor Fhit protein

Regulatory role of phosphorylation of tumor suppressor Fhit protein
抑癌Fhit蛋白磷酸化的调节作用
批准号:
17590275
负责人:
ISHII Hideshi
金额:
$2.01万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2007

项目摘要

项目成果

ISHII Hideshi的其他基金

相似基金

相关文献

中文摘要
翻译
脆弱的FHIT基因是肿瘤前病变中DNA损伤的首要目标之一,最近的研究表明,FHIT蛋白参与基因毒素暴露后基因组完整性和检查点反应的监测。我们研究了Fhit通过调控Fhit蛋白Y114的磷酸化来调节检查点反应。这种反应是由Atr激酶调节的,并确定了正常细胞和癌细胞的反应性。此外,在野生型造血细胞中观察到,暴露于基因毒素对苯二酚的fhit缺陷造血细胞对干细胞体外集落形成的抑制具有抗性。目前的研究结果表明,氧化应激的降低,加上有效但容易出错的DNA损伤修复,使得携带有害突变的基因毒素暴露的fhit缺陷造血干细胞能够在计划外的长期存活,这表明它在多步骤癌变中具有重要意义。
英文摘要
The fragile FHIT gene is among the first targets of DNA damage in preneoplastic lesions and recent studies have shown that Fhit protein is involved in surveillance of genome integrity and checkpoint response after genotoxin exposure. We studied that Fhit modulate the checkpoint response via regulation of phosphorylation at Y114 of Fhit protein. The response was regulated Atr kinase, and define the responsiveness of normal and cancer cells. Furthermore, Fhit-deficient hematopoietic cells, exposed to the genotoxin hydroquinone, are resistant to the suppression of stem cell in vitro colony formation observed with wild type hematopoietic cells. The present results indicate that reduced oxidative stress, coupled with efficient but error-prone DNA damage repair, allows unscheduled, long-term survival of genotoxin-exposed Fhit-deficient hematopoietic stem cells carrying deleterious mutations, suggesting the significance in the multistep carcinogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1002/jso.20426
发表时间: 2006-01-01
期刊: JOURNAL OF SURGICAL ONCOLOGY
影响因子: 2.5
作者: [Mimori, K, Nagahara, H, Mori, M]
通讯作者: Mori, M
DOI: 10.1158/0008-5472.can-05-2509
发表时间: 2006-03-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者: [Mimori, K, Ishii, H, Mori, M]
通讯作者: Mori, M
Histone deacetylase inhibitor depsipeptide (FK228) induces apoptosis in leukemic cells by facilitating mitochondrial translocation of Bax, which is enhanced by the proteasome inhibitor bortezomib.
组蛋白脱乙酰酶抑制剂 depsipeptide (FK228) 通过促进 Bax 的线粒体易位诱导白血病细胞凋亡,蛋白酶体抑制剂硼替佐米可增强这种易位。
DOI: --
发表时间: 2006
期刊: Acta Haematol. 115・1-2
影响因子: --
作者: [Sutheesophon, K.]
通讯作者: K.
DOI: 10.1089/dna.2005.24.432
发表时间: 2005-07
期刊: DNA and cell biology
影响因子: 3.1
作者: [H. Ishii;K. Mimori;M. Mori;A. Vecchione]
通讯作者: H. Ishii;K. Mimori;M. Mori;A. Vecchione
8
    Maximum performance and practical application of cancer biomarkers by measuring RNA methylation of extracellular vesicles
    • 批准号:
      19K22658
    • 项目类别:
      Grant-in-Aid for Challenging Research (Exploratory)
    • 资助金额:
      $4.08万
    • 财政年份:
      2019
    • 负责人:
      ISHII Hideshi
    • 依托单位:
    International collaborative research for liquid biopsy and precision medicine by microfluidic technologies to extracellular vesicles
    • 批准号:
      18KK0251
    • 项目类别:
      Fund for the Promotion of Joint International Research (Fostering Joint International Research (B))
    • 资助金额:
      $11.65万
    • 财政年份:
      2018
    • 负责人:
      ISHII Hideshi
    • 依托单位:
    Foundation construction and clinical application of next-generation RNA biomarker
    • 批准号:
      17H04282
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.9万
    • 财政年份:
      2017
    • 负责人:
      ISHII Hideshi
    • 依托单位:
    New construction of in vivo reprogramming technology by modified microRNA
    • 批准号:
      15K15496
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2015
    • 负责人:
      ISHII Hideshi
    • 依托单位:
    海外基金